As of 2025-05-15, the EV/EBITDA ratio of Legend Biotech Corp (LEGN) is -34.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LEGN's latest enterprise value is 5,211.08 mil USD. LEGN's TTM EBITDA according to its financial statements is -151.21 mil USD. Dividing these 2 quantities gives us the above LEGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 13.1x | 13.0x |
| Forward P/E multiples | 18.5x - 47.3x | 32.9x |
| Fair Price | (15.45) - (11.04) | (19.07) |
| Upside | -155.6% - -139.7% | -168.6% |
| Date | EV/EBITDA |
| 2025-05-14 | -34.46 |
| 2025-05-13 | -38.48 |
| 2025-05-12 | -40.07 |
| 2025-05-09 | -39.34 |
| 2025-05-08 | -39.65 |
| 2025-05-07 | -38.96 |
| 2025-05-06 | -38.83 |
| 2025-05-05 | -41.32 |
| 2025-05-02 | -41.04 |
| 2025-05-01 | -42.01 |
| 2025-04-30 | -43.22 |
| 2025-04-29 | -42.58 |
| 2025-04-28 | -42.91 |
| 2025-04-25 | -42.40 |
| 2025-04-24 | -42.35 |
| 2025-04-23 | -42.42 |
| 2025-04-22 | -42.64 |
| 2025-04-21 | -39.90 |
| 2025-04-17 | -40.59 |
| 2025-04-16 | -41.39 |
| 2025-04-15 | -41.74 |
| 2025-04-14 | -39.74 |
| 2025-04-11 | -39.61 |
| 2025-04-10 | -38.72 |
| 2025-04-09 | -39.70 |
| 2025-04-08 | -38.10 |
| 2025-04-07 | -37.46 |
| 2025-04-04 | -39.62 |
| 2025-04-03 | -40.68 |
| 2025-04-02 | -41.12 |
| 2025-04-01 | -39.02 |
| 2025-03-31 | -41.97 |
| 2025-03-28 | -43.35 |
| 2025-03-27 | -43.76 |
| 2025-03-26 | -42.88 |
| 2025-03-25 | -43.34 |
| 2025-03-24 | -44.91 |
| 2025-03-21 | -45.67 |
| 2025-03-20 | -46.61 |
| 2025-03-19 | -47.05 |
| 2025-03-18 | -46.81 |
| 2025-03-17 | -46.88 |
| 2025-03-14 | -45.97 |
| 2025-03-13 | -47.01 |
| 2025-03-12 | -47.25 |
| 2025-03-11 | -45.96 |
| 2025-03-10 | -42.09 |
| 2025-03-07 | -43.60 |
| 2025-03-06 | -42.28 |
| 2025-03-05 | -42.91 |